Dr. Namandjé Bumpus, Ph.d. - Chief Scientist - U.s. Food And Drug Administration

Dr. Namandjé Bumpus, Ph.D. - Chief Scientist - U.S. Food and Drug Administration (FDA)

Progress, Potential, and Possibilities

Meet FDA's Chief Scientist, Dr. Namandjé Bumpus

U.S. Food and Drug Administration

Dr Namandjé Bumpus, PhD, Chief Scientist, Food and Drug Administration (FDA) - Regulatory Innovation

Progress, Potential, and Possibilities

A Conversation With Janet Woodcock, M.D. and Namandjé Bumpus, Ph.D.

U.S. Food and Drug Administration

Dean Rothman Talks with Namandje Bumpus, Director, Department of Pharmacology & Molecular Sciences

Johns Hopkins Medicine

About Formaldehyde and Formaldehyde-Releasing Chemicals

U.S. Food and Drug Administration

Interview with Drug Metabolism Scientist Dr. Namandjé Bumpus

National Institute of General Medical Sciences

2023 FDA Science Forum: Advancing Regulatory Science Through Innovation

U.S. Food and Drug Administration

2024 CERSI Summit - Panel 4: FDA Center Directors Forum

UCSF-Stanford CERSI

2023 NanoDay Symposium: Continuous Manufacturing of Nanomaterials - Part 1

U.S. Food and Drug Administration

Namandjé N. Bumpus, PhD - How Racism and Sexism Squash Talent and Slow Progress in STEM

Women in Science and Healthcare

74th Cellular, Tissue, and Gene Therapies Advisory Committee

U.S. Food and Drug Administration

Generic Drugs Forum (GDF) 2023: Celebrating 10 Years of the GDF – Day 2 – Session 1

U.S. Food and Drug Administration

Navigating the Early-Career Faculty Years

Faculty Factory Podcast | Johns Hopkins Medicine

Remarks by Dr. Robert Califf to the 2023 Food and Drug Law Institute Annual Conference – 05/17/2023

U.S. Food and Drug Administration

Get To Know a Scientist: Sandra Suarez-Sharp

Simulations Plus, Inc.

Policy Implementation for Increasing Diversity in Clinical Trials: Can FDORA Get Us There?

BlackDoctor.org

Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees (Morning Portion)

U.S. Food and Drug Administration